GoodRx Holdings (GDRX) Total Debt (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Total Debt data on file, last reported at $487.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 0.7% year-over-year to $487.4 million; the trailing twelve-month figure through Mar 2026 stood at $487.4 million (down 0.7% YoY), and the FY2025 full-year result was $488.3 million, down 0.7% from the prior year.
• Total Debt held at $487.4 million in Q1 2026, from $488.3 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $661.9 million in Q1 2022 to a low of $487.4 million in Q1 2026.
• A 5-year average of $588.4 million and a median of $653.7 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt fell 0.35% in 2023 and dropped 25.1% in 2024, its largest moves.
• Tracing GDRX's Total Debt over 5 years: stood at $658.8 million in 2022, then declined by 0.35% to $656.5 million in 2023, then retreated by 25.1% to $491.7 million in 2024, then fell by 0.7% to $488.3 million in 2025, then declined by 0.17% to $487.4 million in 2026.
• Business Quant data shows GDRX's Total Debt at $487.4 million in Q1 2026, $488.3 million in Q4 2025, and $489.1 million in Q3 2025.